Free Trial

Aspen Aerogels, Inc. (NYSE:ASPN) Stake Boosted by Loomis Sayles & Co. L P

Aspen Aerogels logo with Construction background

Loomis Sayles & Co. L P raised its holdings in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 22.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,619,320 shares of the construction company's stock after purchasing an additional 300,076 shares during the quarter. Loomis Sayles & Co. L P owned about 1.97% of Aspen Aerogels worth $44,839,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the business. Penserra Capital Management LLC purchased a new stake in Aspen Aerogels during the 3rd quarter valued at approximately $1,342,000. Algert Global LLC grew its position in Aspen Aerogels by 60.2% in the 3rd quarter. Algert Global LLC now owns 127,764 shares of the construction company's stock valued at $3,538,000 after buying an additional 48,007 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in Aspen Aerogels by 204.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 509,430 shares of the construction company's stock valued at $14,106,000 after buying an additional 342,253 shares during the period. Intech Investment Management LLC purchased a new position in Aspen Aerogels during the 3rd quarter worth $497,000. Finally, Quest Partners LLC boosted its holdings in shares of Aspen Aerogels by 263.3% in the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company's stock valued at $205,000 after acquiring an additional 5,361 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the business's stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company's stock, valued at approximately $14,523,709.20. The trade was a 11.58 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 4.30% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the stock. Barclays cut their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating for the company in a report on Tuesday, November 12th. TD Cowen raised their price target on Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a report on Tuesday, August 20th. StockNews.com raised Aspen Aerogels to a "sell" rating in a report on Wednesday, November 13th. Benchmark restated a "buy" rating and set a $14.00 target price on shares of Aspen Aerogels in a research report on Thursday, August 8th. Finally, Roth Mkm cut their price target on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating for the company in a report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $28.70.

Read Our Latest Analysis on Aspen Aerogels

Aspen Aerogels Stock Down 4.8 %

NYSE:ASPN traded down $0.72 during trading hours on Tuesday, hitting $14.33. The stock had a trading volume of 1,878,972 shares, compared to its average volume of 1,634,595. The business has a 50 day simple moving average of $20.69 and a two-hundred day simple moving average of $24.15. Aspen Aerogels, Inc. has a 1-year low of $10.31 and a 1-year high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The company has a market cap of $1.18 billion, a PE ratio of 1,433.00 and a beta of 2.21.

Aspen Aerogels Profile

(Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Should you invest $1,000 in Aspen Aerogels right now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines